Semaglutide can affect your period indirectly
If weight remains stable for another four to six weeks, further reduction may be possible
Tirzepatide (brand name Mounjaro) is a dual GLP-1 and GIP receptor agonist injected once per week that has shown weight loss of up to 21% in clinical trials
But sometimes, the commercially manufactured versions arent available or they may not be medically appropriate for an individual patient
For reference, the pivotal obesity trials enrolled adults with a body mass index of 30 kg/m or greater, or 27 kg/m or greater with at least one weight-related comorbid condition
Adequate hydration with water, herbal teas, and clear broths remains essential, as reduced food intake may decrease overall fluid consumption